Rocuronium Bromide
Who holds supplier records for Rocuronium Bromide? 12 organisations hold a current record for Rocuronium Bromide: an active US FDA Type II Drug Master File or a CEP. A further 3 organisations have only historical (inactive) DMF filings. 9 of them hold a valid EU Certificate of Suitability (11 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (3), China (3), Netherlands (2), Italy (1) and 2 other countries (2); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Rocuronium Bromide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/rocuronium-bromide
Reading the evidence
- 12 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 6 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (12)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Rocuronium Bromide. Country is the organisation's recorded country, not necessarily the manufacturing site.
- ASPEN OSS BVNetherlandsCEP Company GMP cert on recordActive DMF 9854 · latest filing Sept 1992
- CURIA ITALY SRLItalyCEP Company GMP cert on recordActive DMF 34252 · latest filing Dec 2019
- FARMHISPANIA SASpainCEPActive DMF 19819 · latest filing Sept 2006
- GLAND PHARMA LTDIndiaCEP Company GMP cert on recordActive DMF 20833 · latest filing Sept 2007
- Mankind Pharma LimitedIndiaCEP Company GMP cert on recordActive DMF 39437 · latest filing Mar 2024
- SHANGHAI JUNMED HEALTHCARE CO LTDChinaCEPActive DMF 37698 · latest filing Jan 2023
- TAPI NL BVNetherlandsCEPActive DMF 20068 · latest filing Dec 2006
- Zhejiang Huahai Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 29741 · latest filing Sept 2015
- ZHEJIANG XIANJU PHARMACEUTICAL CO LTDCEPActive DMF 26765 · latest filing Dec 2012
- CHENGDU SINO-STRONG PHARMACEUTICAL CO LTDChinaActive DMF 34057 · latest filing Oct 2019
- Gland Chemicals Private LimitedIndiaActive DMF 26441 · latest filing Oct 2012
- WAVELENGTH ENTERPRISES LTDIsrael Company GMP cert on recordActive DMF 19572 · latest filing Jun 2006
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (11)
Certificates of Suitability on the EDQM register for Rocuronium Bromide, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 14 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| FARMHISPANIA S.A. Montmelo | ES | CEP 2023-131 - Rev 03 Rocuronium bromide, Process II | Jul 2026 | Inspected May 2023 Spain, outside 3-year window |
| GLAND PHARMA LIMITED Visakhapatnam | IN | CEP 2023-174 - Rev 00 Rocuronium bromide | Dec 2025 | — |
| MANKIND PHARMA LIMITED New Delhi | IN | CEP 2024-337 - Rev 00 Rocuronium bromide | Aug 2025 | — |
| ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD. Taizhou | CN | CEP 2025-319 - Rev 00 Rocuronium bromide, Process II | Aug 2025 | — |
| SHANGHAI JUNMED HEALTHCARE CO., LTD Shanghai | CN | CEP 2023-169 - Rev 00 Rocuronium bromide | May 2025 | — |
| TAPI NL B.V. Amsterdam | NL | CEP 2010-023 - Rev 06 Rocuronium bromide | Mar 2025 | — |
| ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Linhai | CN | CEP 2024-267 - Rev 00 Rocuronium bromide, Acetone process | Sept 2024 | Inspected May 2026 Italy |
| CURIA ITALY S.R.L. Rozzano, Milano | IT | CEP 2015-113 - Rev 01 Rocuronium bromide | Apr 2024 | Inspected Dec 2024 Italy |
| ASPEN OSS B.V. Oss | NL | R1-CEP 2009-231 - Rev 02 Rocuronium bromide | Nov 2022 | — |
| Farmhispania, S.A. Montmeló | ES | R1-CEP 2006-176 - Rev 02 Rocuronium bromide | Aug 2022 | — |
| ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD. Xianju | CN | R1-CEP 2013-065 - Rev 01 Rocuronium bromide | May 2021 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (3)
Organisations whose Type II DMFs for Rocuronium Bromide are no longer active. These show a past filing, not current supply.
Show all 3 historical records
- AMRI ITALY SRLInactive DMF 25622 · filed Dec 2011
- India · Inactive DMF 25156 · filed Nov 2011
- India · Inactive DMF 20861 · filed Sept 2007
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Rocuronium Bromide is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1200648).
Chemical identity
- IUPAC name
- [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3-hydroxy-10,13-dimethyl-2-morpholin-4-yl-16-(1-prop-2-enylpyrrolidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate bromide
- Canonical SMILES
- CC(=O)O[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C.[Br-]
- InChIKey
- OYTJKRAYGYRUJK-FMCCZJBLSA-M
- Synonyms
- Bromure de rocuronium, Bromuro de rocuronio, Esmeron, ORG 9426, ORG-9426, Rocuronium bromide, Zemuron, org9426, CHEBI:8885, rocuronii bromidum, RefChem:56464, M03AC09
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Nondepolarizing Neuromuscular Blocker
- Physiologic effect
- Neuromuscular Nondepolarizing Blockade
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Rocuronium Bromide?
12 organisations hold an active US FDA Type II Drug Master File or a CEP for Rocuronium Bromide: ASPEN OSS BV (Netherlands), CURIA ITALY SRL (Italy), FARMHISPANIA SA (Spain), GLAND PHARMA LTD (India), Mankind Pharma Limited (India), SHANGHAI JUNMED HEALTHCARE CO LTD (China), TAPI NL BV (Netherlands) and Zhejiang Huahai Pharmaceutical Co., Ltd. (China), and 4 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Rocuronium Bromide Drug Master Files are active?
ASPEN OSS BV (DMF 9854), CURIA ITALY SRL (DMF 34252), FARMHISPANIA SA (DMF 19819), GLAND PHARMA LTD (DMF 20833), Mankind Pharma Limited (DMF 39437), SHANGHAI JUNMED HEALTHCARE CO LTD (DMF 37698), TAPI NL BV (DMF 20068) and Zhejiang Huahai Pharmaceutical Co., Ltd. (DMF 29741) and 4 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Rocuronium Bromide records mean?
3 organisations have only inactive Type II DMFs for Rocuronium Bromide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Rocuronium Bromide have a European Certificate of Suitability?
Yes. 9 organisations hold a valid CEP for Rocuronium Bromide on the EDQM register, including FARMHISPANIA S.A. Montmelo (ES), GLAND PHARMA LIMITED Visakhapatnam (IN), MANKIND PHARMA LIMITED New Delhi (IN), ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD. Taizhou (CN), SHANGHAI JUNMED HEALTHCARE CO., LTD Shanghai (CN) and TAPI NL B.V. Amsterdam (NL) and 5 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Rocuronium Bromide supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Rocuronium Bromide?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.